A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.7744-7746
Hauptverfasser: Filippini Velazquez, Giuliano, Labopin, Myriam, Tischer, Johanna, Angelucci, Emanuele, Kulagin, Alexander D., Galieni, Piero, Bermúdez, Arancha, Bulabois, Claude-Eric, Kröger, Nicolaus, Díez-Martin, José Luis, Nagler, Arnon, Schmid, Christoph, Ciceri, Fabio, Mohty, Mohamad
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7746
container_issue Supplement 1
container_start_page 7744
container_title Blood
container_volume 140
creator Filippini Velazquez, Giuliano
Labopin, Myriam
Tischer, Johanna
Angelucci, Emanuele
Kulagin, Alexander D.
Galieni, Piero
Bermúdez, Arancha
Bulabois, Claude-Eric
Kröger, Nicolaus
Díez-Martin, José Luis
Nagler, Arnon
Schmid, Christoph
Ciceri, Fabio
Mohty, Mohamad
description
doi_str_mv 10.1182/blood-2022-160229
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_160229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122050030</els_id><sourcerecordid>S0006497122050030</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1379-24d1bf1d9f0da29472c6e73abc57c754ccc839b5549ccfa425c60757b396f7c83</originalsourceid><addsrcrecordid>eNp9Uk2P0zAQDQgkysIP4DbH7SFgu0nTiFOabelKqbaihT1GE2dCzaZxZDug_nucbTkhcbEP875m9ILgA2cfOV-IT1WrdR0KJkTI5_5NXwYTHotFyJhgr4IJY2weRmnC3wRvrf3JGI9mIp68-J7BnqTuathg32pVU-eUxBb2jk6QU9vCwWBn-xY7h07pDm432a54CPf5QUwBG0cGvlKLvSVojD7BWhnrLnIjCO4trAmtqloC9EY7o-tBkvUsO7TOwuGIDjJDkOtTjwZHoNNwhw49ptfGUX01umYdZVXn1WBTZOEWnTx6yJ6cU90PCAF9_KE-g0-7pCO2DegG3JEgk4MjKGh4QjophEdtnkbKDo07w21WPO6mf7GrweievMdeS0V-3GgDy_HOz2ts0Rj9-9_rrJbbw_Rd8LrB1tL7638TfFuvDvkmLB6-3OdZEUo-S9JQRDWvGl6nDatRpFEi5JySGVYyTmQSR1LKxSyt4jhKpWwwErGcsyROqlk6bxI_uwn4RVcaba2hpuyNOqE5l5yVYzHK52KUYzHKSzE85_OFQz7YL0WmtH6_TlKtDElX1lr9h_0H92HClg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Filippini Velazquez, Giuliano ; Labopin, Myriam ; Tischer, Johanna ; Angelucci, Emanuele ; Kulagin, Alexander D. ; Galieni, Piero ; Bermúdez, Arancha ; Bulabois, Claude-Eric ; Kröger, Nicolaus ; Díez-Martin, José Luis ; Nagler, Arnon ; Schmid, Christoph ; Ciceri, Fabio ; Mohty, Mohamad</creator><creatorcontrib>Filippini Velazquez, Giuliano ; Labopin, Myriam ; Tischer, Johanna ; Angelucci, Emanuele ; Kulagin, Alexander D. ; Galieni, Piero ; Bermúdez, Arancha ; Bulabois, Claude-Eric ; Kröger, Nicolaus ; Díez-Martin, José Luis ; Nagler, Arnon ; Schmid, Christoph ; Ciceri, Fabio ; Mohty, Mohamad</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-160229</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.7744-7746</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Filippini Velazquez, Giuliano</creatorcontrib><creatorcontrib>Labopin, Myriam</creatorcontrib><creatorcontrib>Tischer, Johanna</creatorcontrib><creatorcontrib>Angelucci, Emanuele</creatorcontrib><creatorcontrib>Kulagin, Alexander D.</creatorcontrib><creatorcontrib>Galieni, Piero</creatorcontrib><creatorcontrib>Bermúdez, Arancha</creatorcontrib><creatorcontrib>Bulabois, Claude-Eric</creatorcontrib><creatorcontrib>Kröger, Nicolaus</creatorcontrib><creatorcontrib>Díez-Martin, José Luis</creatorcontrib><creatorcontrib>Nagler, Arnon</creatorcontrib><creatorcontrib>Schmid, Christoph</creatorcontrib><creatorcontrib>Ciceri, Fabio</creatorcontrib><creatorcontrib>Mohty, Mohamad</creatorcontrib><title>A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9Uk2P0zAQDQgkysIP4DbH7SFgu0nTiFOabelKqbaihT1GE2dCzaZxZDug_nucbTkhcbEP875m9ILgA2cfOV-IT1WrdR0KJkTI5_5NXwYTHotFyJhgr4IJY2weRmnC3wRvrf3JGI9mIp68-J7BnqTuathg32pVU-eUxBb2jk6QU9vCwWBn-xY7h07pDm432a54CPf5QUwBG0cGvlKLvSVojD7BWhnrLnIjCO4trAmtqloC9EY7o-tBkvUsO7TOwuGIDjJDkOtTjwZHoNNwhw49ptfGUX01umYdZVXn1WBTZOEWnTx6yJ6cU90PCAF9_KE-g0-7pCO2DegG3JEgk4MjKGh4QjophEdtnkbKDo07w21WPO6mf7GrweievMdeS0V-3GgDy_HOz2ts0Rj9-9_rrJbbw_Rd8LrB1tL7638TfFuvDvkmLB6-3OdZEUo-S9JQRDWvGl6nDatRpFEi5JySGVYyTmQSR1LKxSyt4jhKpWwwErGcsyROqlk6bxI_uwn4RVcaba2hpuyNOqE5l5yVYzHK52KUYzHKSzE85_OFQz7YL0WmtH6_TlKtDElX1lr9h_0H92HClg</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Filippini Velazquez, Giuliano</creator><creator>Labopin, Myriam</creator><creator>Tischer, Johanna</creator><creator>Angelucci, Emanuele</creator><creator>Kulagin, Alexander D.</creator><creator>Galieni, Piero</creator><creator>Bermúdez, Arancha</creator><creator>Bulabois, Claude-Eric</creator><creator>Kröger, Nicolaus</creator><creator>Díez-Martin, José Luis</creator><creator>Nagler, Arnon</creator><creator>Schmid, Christoph</creator><creator>Ciceri, Fabio</creator><creator>Mohty, Mohamad</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)</title><author>Filippini Velazquez, Giuliano ; Labopin, Myriam ; Tischer, Johanna ; Angelucci, Emanuele ; Kulagin, Alexander D. ; Galieni, Piero ; Bermúdez, Arancha ; Bulabois, Claude-Eric ; Kröger, Nicolaus ; Díez-Martin, José Luis ; Nagler, Arnon ; Schmid, Christoph ; Ciceri, Fabio ; Mohty, Mohamad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1379-24d1bf1d9f0da29472c6e73abc57c754ccc839b5549ccfa425c60757b396f7c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Filippini Velazquez, Giuliano</creatorcontrib><creatorcontrib>Labopin, Myriam</creatorcontrib><creatorcontrib>Tischer, Johanna</creatorcontrib><creatorcontrib>Angelucci, Emanuele</creatorcontrib><creatorcontrib>Kulagin, Alexander D.</creatorcontrib><creatorcontrib>Galieni, Piero</creatorcontrib><creatorcontrib>Bermúdez, Arancha</creatorcontrib><creatorcontrib>Bulabois, Claude-Eric</creatorcontrib><creatorcontrib>Kröger, Nicolaus</creatorcontrib><creatorcontrib>Díez-Martin, José Luis</creatorcontrib><creatorcontrib>Nagler, Arnon</creatorcontrib><creatorcontrib>Schmid, Christoph</creatorcontrib><creatorcontrib>Ciceri, Fabio</creatorcontrib><creatorcontrib>Mohty, Mohamad</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Filippini Velazquez, Giuliano</au><au>Labopin, Myriam</au><au>Tischer, Johanna</au><au>Angelucci, Emanuele</au><au>Kulagin, Alexander D.</au><au>Galieni, Piero</au><au>Bermúdez, Arancha</au><au>Bulabois, Claude-Eric</au><au>Kröger, Nicolaus</au><au>Díez-Martin, José Luis</au><au>Nagler, Arnon</au><au>Schmid, Christoph</au><au>Ciceri, Fabio</au><au>Mohty, Mohamad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>7744</spage><epage>7746</epage><pages>7744-7746</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-160229</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.7744-7746
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_160229
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title A Second Haploidentical Stem Cell Transplantation (HAPLO-SCT2) after Relapse from First Haplo-SCT Is Feasible and Produces Results That Are Comparable to Data Reported after Second SCT in an HLA-Matched Setting - a Study on Behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T09%3A45%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Second%20Haploidentical%20Stem%20Cell%20Transplantation%20(HAPLO-SCT2)%20after%20Relapse%20from%20First%20Haplo-SCT%20Is%20Feasible%20and%20Produces%20Results%20That%20Are%20Comparable%20to%20Data%20Reported%20after%20Second%20SCT%20in%20an%20HLA-Matched%20Setting%20-%20a%20Study%20on%20Behalf%20of%20the%20Acute%20Leukaemia%20Working%20Party%20(ALWP)%20of%20the%20European%20Society%20for%20Blood%20and%20Marrow%20Transplantation%20(EBMT)&rft.jtitle=Blood&rft.au=Filippini%20Velazquez,%20Giuliano&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=7744&rft.epage=7746&rft.pages=7744-7746&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-160229&rft_dat=%3Celsevier_cross%3ES0006497122050030%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122050030&rfr_iscdi=true